Novo Holdings takes the lead in investment in new Asian company
Novo Holdings has taken part in a USD 125m investment in Hummingbird Bioscience, one of the first investments which the fund has made through its new Asian department.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Novo Holdings has led a series C investment round at biotech company Hummingbird Bioscience which is headquartered in Singapore and the US.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
